#ATS2019 – Randomized Trial: Early Neuromuscular Blockade Do Not Benefit Patients with Acute Respiratory Distress Syndrome

Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Sedation and controlled paralysis do not improve survival of ICU patients with ARDS – University of Pittsburgh (free)

Just Presented at the 2019 Meeting of the American Thoracic Society.

Related Commentary on Twitter

This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS). See the results of the new trial: https://t.co/lcLOUirsOM #ATS2019

— NEJM (@NEJM) May 19, 2019